538P Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; pp. S602 - S603
Main Authors Awada, A.H., Zematis, M., Ochsenreither, S., Eefsen, R.L., Arnold, D., Cicenas, S., Yachnin, J., Pfeiffer, P., Paz-Ares, L., Jungels, C., Greil, R., Poulsen, L. Østergaard, Van Cutsem, E., Ribas, I. Garcia, Thorsson, L., Collignon, J.J.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2021
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2021.08.1060